{{Drugbox
| verifiedrevid = 443906983
| IUPAC_name = 4-(4-fluorophenyl)-7-methyl-1-propan-2-ylquinazolin-2-one
| image = Fluproquazone.svg

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  

<!--Identifiers-->
| CAS_number = 40507-23-1
| ATC_prefix = none
| PubChem = 38503
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 35289
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U4K85O58HD
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04229

<!--Chemical data-->
| C=18 | H=17 | F=1 | N=2 | O=1 
| molecular_weight = 296.339 g/mol
| smiles = Fc3ccc(C/1=N/C(=O)N(c2cc(ccc\12)C)C(C)C)cc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H17FN2O/c1-11(2)21-16-10-12(3)4-9-15(16)17(20-18(21)22)13-5-7-14(19)8-6-13/h4-11H,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZWOUXWWGKJBAHQ-UHFFFAOYSA-N
}}

'''Fluproquazone''' (trade name '''Tormosyl''', '''RF 46-790''' ) was a [[quinazolinone]] derivative with potent [[analgesic]], [[antipyretic]], and [[anti-inflammatory]] effects discovered by [[Novartis|Sandoz]].<ref>Haanaes HR, et al  RF 46-790 versus paracetamol: effect on post-operative pain. Int J Clin Pharmacol Ther Toxicol. 1986 Nov;24(11):598-601. {{PMID|3491794}}</ref><ref>Mohing W, Suckert R, Lataste X. Comparative study of fluproquazone in the management of post-operative pain. ''Arzneimittelforschung''. 1981;31(5a):918-20.</ref><ref>Wheatley D. Analgesic properties of fluproquazone. ''Rheumatology and Rehabilitation''. 1982 May;21(2):98-100.</ref><ref>Fankhauser S, Laube W, Marti HR, Schultheiss HR, Vogtlin J, von Graffenried B. Antipyretic activity of fluproquazone in man. ''Arzneimittelforschung''. 1981;31(5a):934-5.</ref>  It was withdrawn during development due to [[liver toxicity]].<ref>Lewis JH and Stine JG. Nonsteroidal Antiinflammatory Drugs and Leukotriene Receptor Antagonists, Ch 22 in Drug-induced Liver Disease (Third Edition). Eds Neil Kaplowitz and Laurie D. DeLeve. Elsevier Inc, 2013. {{ISBN|9780123878175}}</ref>{{rp|370}}<ref>Hyman J. Zimmerman. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. Lippincott Williams & Wilkins, 1999. {{ISBN|9780781719520}}</ref>{{rp|520}}

== References ==
<references />

{{NSAIDs}}
{{Prostanoidergics}}

[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Analgesics]]
[[Category:Quinazolines]]
[[Category:Lactams]]
[[Category:Fluoroarenes]]
[[Category:Abandoned drugs]]


{{musculoskeletal-drug-stub}}